Virtual Organ Computer-aided Analysis (VOCAL) technique. Logistic regression models using PET as the outcome were determined for each PVI. Covariates included: study group, age, BMI, smoking status, aspirin use, parity, material deprivation of area of residence and Mean Arterial Pressure (MAP). Results: The overall rate of PET was 12%. No significant differences in age, smoking status, deprivation or MAP were seen between groups. Significant differences in parity (P=0.002), BMI (P<0.001) and aspirin use (P<0.001) were noted. In the logistic regression model, a 1% increase in VI from a mean of 14.2 (SD 7.7) to 15.2% was associated with a 10% reduction in the odds of PET (OR 0.90, 95% CI 0.82-0.98, P=0.02) and a 1 unit increase in FI (mean 42.1, SD 10.3) was associated with a 6% reduction in the odds of PET (OR 0.94, 95% CI 0.89-1.0, P=0.04). A doubling in VFI (median 5.1, IQR 3.4-8.3) was associated with a 57% reduction in the odds of PET (OR 0.43, 95% CI 0.26-0.70, P=0.001). Conclusions: Using logistic regression, VI, FI and VFI were predictive of PET in separate models controlling for confounding variables. This technique may be a useful adjunct for clinicians wishing to refine first trimester screening models to predict PET.
Objectives Screening and assessment of pre-eclampsia by PAPP-A, PlGF, MAP, and mPI at first trimester of gestation. Methods: The study conducted among 361 singleton pregnant women at 11-13 +6 weeks, who were visiting antenatal care services, between March, 2015 and January, 2016 . The cross sectional study design was used to implement this study. The ethical norms of biomedical research were applied throughout the course of study. The PlGF, PAPP-A in plasma were identified by PerkinElmer kits, uterine artery pulsatility index measured by GE ultrasound machine, the blood pressure was measured twice, in each arm of pregnant woman, by Omron blood pressure monitor. Results: The PIGF level of the group with pre-eclampsia complications was 38.6±19.6 pg/ml, in the group without pre-eclampsia level was 45.1±24.0 pg/ml (p=0.010), while PAPP-A concentration in the group with pre-eclampsia was 366.1±195.3 mU/L and 633.6±496.9 mU/L (p=0.003) in the group without pre-eclampsia. MAP 80.1-100 mm Hg group had 20.6 times higher risk of pre-eclampsia in compare to MAP normal group (OR 20.6, p=0.003) . No significant differences observed in mPI of both groups (p=0.222).
The logistic regression analysis shows that pregnant women previous without pre-eclampsia but have MAP more than 80mm Hg, PAPP-A less than 330 mU/L and PIGF less than 35pg/ml or have three risk factors of pre-eclampsia (OR 8.12 p=0.018) have higher level of pre-eclampsia compared to women with 1 or 2 risk factors . Conclusions: In the groups of pregnant women with pre-eclampsia, the levels of PlGF, PAPP-A are lower compared to those, who have no pre-eclampsia. The level of risk of pre-eclampsia for women without previous pre-eclampsia depends on the number of risk factors. Objectives: The purpose of the study was to learn a role of cerebro-placental ratio and cardiothoracic ratio in the degree of perinatal risk determination. Methods: Antenatal US examinations were performed in 1448 fetuses with a high perinatal risk. The study included Doppler assessment of placental profile and fetal cardiovascular profile. Pregnancy outcomes and neonatal status were studied. Postnatal results were classified as adverse general postnatal outcome which meant perinatal or infant death and adverse clinical postnatal outcome which meant perinatal acidemia, Apgar score of 0-4 points, persistent pathological condition of the newborn. All the fetuses of the studied cohort were divided into two clinical groups: 638 fetuses with poor general postnatal outcome and/or clinical postnatal outcome (I group) and 810 fetuses with favourable clinical postnatal outcome (II group).
Results:
The most significant differences occurred at the frequency of registration ductus venosus (DV) a-reverse wave, p<0.01. The increased cardio-thoracic ratio (CTR) occurred in fetuses of group I 9 times more frequent than of group II. The cerebroplacental ratio (CPR) reduction occurred 18 times, the prevalence of reverse flow component of the fetal aortic isthmus 6,2 times and the deepening of ductus venosus myocardial isovolumetric relaxation phase in the group I were registered 21 times more often than in group II, however these differences did not have statistical significance due to the small number of observations. Conclusions: Taking into account the limited possibilities of single centre study should be considered as necessary further multicentre studies of the role of fetal CTR and CPR as predictors of adverse pregnancy outcomes, in order to include these aspects in obstetrical management protocols of high perinatal risk fetuses monitoring to determine the perinatal risk degree ant to choose the best point for delivery.
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Association between uterine artery blood flow volume and fetal weight gain Objectives: The aim of the study was to explore an eventual association between blood flow measured by PixelFlux in second trimester and fetal weight gain/day. Methods: We conducted a prospective cohort study in 47 women with single pregnancies in week 24. PixelFlux is a new method based on pixelwise calculation of spatially angle-corrected velocities and areas of all pixels inside a vessel. Velocity is coded by colour, and by comparing the colour of each pixel in the cross-sectional area with the preset colour bar, it is possible to measure blood flow velocities directly. Then, all pixels' flow volumes inside a vessels section are added to calculate the flow volume of the vessel during a heart cycle. Fetal weight in the second trimester was estimated from biparietal diameter and abdominal circumference using the eSnurra algorithm. Mean fetal weight gain/day was calculated as the difference between birthweight and estimated fetal weight in the second trimester, and thereafter related to the remaining days in pregnancy from the ultrasound examination to delivery. Results: We observed a significant association between mean flow calculated from PixelFlux and weight gain/day (r =0.33; p =0.02) as presented in the Figure. The correlations remained significant after adjusting for maternal age, BMI, parity and systolic blood pressure (p =0.01 and p =0.02, respectively). Conclusions: We found a significant association between total blood flow based on PixelFlux and fetal weight-gain/day. The PixelFlux method might be a promising tool in predicting birthweight.
Supporting information can be found in the online version of this abstract 
Objectives:
We assessed the ultrasound pattern of visceral abdominal fat (VAT) in adequate weight, overweight and obese pregnant patients and estimate misclassification of metabolic risk. Methods: We evaluated 61 outpatients in the first 20 weeks of pregnancy. Pre-pregnancy weight was obtained through first medical evaluation and height was measured in the clinic. VAT was measured using ultrasound according the Armellini technique. We used two cut off measures to identify abnormal VAT. A normal VAT lower of 36.6 mm was based on means of 3 previous studies in pregnant women (normal cut-off). VAT higher than 47.3 mm was used as high risk for diabetes, as previously reported (diabetes cut-off). Patients were divided in adequate weight or pre-pregnant maternal (BMI) ∠25 kg/m2, overweight or BMI 25-29.9 kg/m 2 and obese BMI 30 kg/m 2 .
Results:
We found a strong correlation between BMI and VAT (r=0.58, p∠0.001). Mean VAT was 35.3 ± 11.4mm in adequate weight group, 40.0 ± 8.6mm in overweight group and 50.1± 20.4mm among obese patients. Among adequate weight patients we found that 42.3% had VAT higher than normal cut-off and 11.5% higher than diabetes cut-off. In the overweight group, 71.4% had VAT higher than normal cut-off and 21.4% had higher than diabetes cut-off. In the obese group 81.0% had VAT above normal cut-off and 42.9% had VAT higher than diabetes cut-off. For the diabetes cut-off of VAT, 11.5% of adequate weight and 21.4% of overweight was misclassified between low and intermediate metabolic risk. Conclusions: BMI values are traditionally used to classify the metabolic risk during pregnancy, but it can be misclassifying an important number of patients. VAT measures trough ultrasound can be add information for better classification, but more studies are needed to establish a reliable cut-off for diabetes and other unfavourable outcomes in pregnancy.
